Article

Atopic Dermatitis Beyond the Skin Barrier: Precision Medicine Approaches to Immunological Profiling and Therapeutic Innovation

2026-05-15

Abstract excerpt

Atopic dermatitis (AD) is a chronic, relapsing inflammatory skin disease characterized by substantial clinical and immunological heterogeneity. Traditionally considered a disorder of epidermal barrier dysfunction primarily, AD is now increasingly recognized as a complex systemic inflammatory condition involving dysregulated immune responses, epithelial-derived signaling, neuroimmune interactions, and diverse molec...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 70469960-2042-53a3-9d43-46e7a50b85f8
DOI: 10.20944/preprints202605.1051.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Atopic Dermatitis Beyond the Skin Barrier: Precision Medicine Approaches to Immunological Profiling and Therapeutic InnovationDOI 10.20944/preprints202605.1051.v1Read

The translational revolution in atopic dermatitis: the paradigm shift from pathogenesis to treatment.Semantic proximity Read

Deciphering atopic dermatitis heterogeneity: a short review on the translational revolution from endotypes to immunotypes.Semantic proximity Read

Recent Advancements in the Atopic Dermatitis Mechanism.Semantic proximity Read

Endotypes of Atopic Dermatitis: Correspondence to Classical SubtypesSemantic proximity Read

Untangling the Complexity of Childhood Atopic Dermatitis: Phenotypes and Endotypes.Semantic proximity Read

Biomarkers for phenotype-endotype relationship in atopic dermatitis: a critical review.Semantic proximity Read

Update on the pathogenesis of atopic dermatitis.Semantic proximity Read

Atopic dermatitis.Semantic proximity Read

Clinical phenotypes and endophenotypes of atopic dermatitis: Where are we, and where should we go?Semantic proximity Read

So close, and yet so far away: The dichotomy of the specific immune response and inflammation in psoriasis and atopic dermatitis.Semantic proximity Read

Integrating multi‐omics approaches in deciphering atopic dermatitis pathogenesis and future therapeutic directionsSemantic proximity Read

Targeting <scp>IL</scp>‐13 with tralokinumab normalizes type 2 inflammation in atopic dermatitis both early and at 2 yearsSemantic proximity Read